Department of General Surgery, Faculty of Medicine, Vasile Goldiș Western University of Arad, Arad, Romania.
Department of General Surgery, Arad County Emergency University Hospital, Arad, Romania.
J Med Life. 2023 Feb;16(2):186-188. doi: 10.25122/jml-2022-0173.
Serological analysis of tumor markers has emerged as a non-invasive method for monitoring cancer patients, including tumor recurrence and response to treatment. Tumor markers have the potential to aid in both the diagnosis and prognosis of cancer, but their most important role currently lies in the monitoring of tumor progression. Tumor markers can also provide valuable information on treatment effectiveness, with changes in plasma values indicating tumor regression or progression. This research aimed to investigate the correlation between the serum detection values of three tumor markers - CEA, CA 19-9, and CA 72-4 - and their utility in the diagnosis and prognosis of patients with gastric cancer. The study seeks to uncover the relationship between these tumor markers and the evolution of gastric cancer, providing insights into their potential use in clinical practice.
血清肿瘤标志物分析已成为监测癌症患者(包括肿瘤复发和对治疗的反应)的一种非侵入性方法。肿瘤标志物有可能有助于癌症的诊断和预后,但它们目前最重要的作用在于监测肿瘤的进展。肿瘤标志物还可以为治疗效果提供有价值的信息,血浆值的变化表明肿瘤的消退或进展。本研究旨在探讨三种肿瘤标志物(CEA、CA19-9 和 CA72-4)的血清检测值之间的相关性及其在胃癌患者诊断和预后中的应用。本研究旨在揭示这些肿瘤标志物与胃癌演变之间的关系,为其在临床实践中的潜在应用提供依据。